Loading, Please Wait...
SANTA CLARA, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced the company will participate in a fireside chat with analysts and investors at the upcoming 39th Annual Canaccord Genuity Global Growth Conference being held from August 7-8, 2019 in Boston, MA.
The Shockwave session is scheduled to take place Wednesday, August 7, 2019 at 8:30 a.m. Eastern Time. Investors and the general public are invited to listen to a live webcast of the presentation at https://ir.shockwavemedical.com/. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the presentation will be available later that day.
About Shockwave Medical, Inc.
Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated by establishing a new standard of care with Intravascular Lithotripsy (IVL) technology. The company’s differentiated and proprietary IVL approach to calcium modification uses sonic pressure waves to safely and effectively fracture problematic calcium throughout the cardiovascular system in a wide and growing number of applications. For more information, visit www.shockwavemedical.com.
Debbie Kaster, Gilmartin Group